Additional strength Biowaiver [Dissolution / BCS / IVIVC]

posted by wienui  – Germany, Oman, 2020-07-18 18:00 (232 d 23:50 ago) – Posting: # 21742
Views: 847

Dear dshah & All,

» I believe 2.5X8 tab Vs 20 mg, 10X2 tab vs 20 mg and 15 vs 20 mg strength using 0.4% SDS media is one of the option, but is there any other options for dissolution comparision?

Yes, I think your suggestion for the in vitro comparative dissolution testing for the other additional strength biowaivers is correct. ( take care of the sink conditions).

Beside the dissolution, the followings have to be fulfilled (EMA):

- Amount of API must be < 5% of tablet core weight in the BE strength and the biowaiver strength, and
- Amounts of excipients are same per strength, or
- Only the amount of a filler is changed to account for changes in API weight.

Cheers,
Osama

Complete thread:

Activity
 Admin contact
21,371 posts in 4,463 threads, 1,495 registered users;
online 5 (0 registered, 5 guests [including 2 identified bots]).
Forum time: Monday 16:50 CET (Europe/Vienna)

When puzzled, it never hurts to read the primary documents 
a rather simple and self-evident principle that has, nonetheless,
completely disappeared from large sectors
of the American experience.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5